2377610-25-6
中文名稱
Palbociclib Impurity 3
英文名稱
Palbociclib Impurity 3
CAS
2377610-25-6
分子式
C11H21BF3NO4
分子量
299.1
MOL 文件
2377610-25-6.mol
更新日期
2025/10/27 11:45:32
2377610-25-6 結(jié)構(gòu)式
基本信息
中文別名
帕布昔利布雜質(zhì)G帕布西里布雜質(zhì)3
3-(四甲基-1,3,2-二氧雜硼環(huán)戊烷-2-基)丙-1-胺
英文別名
Pabuxirib Impurity GPalbociclib Impurity 3
Trifluoroacetic acid salt
3-(Tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-amine
8-cyclopentyl-5-methyl-2,6-bis((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
應(yīng)用領(lǐng)域
用途一
8-Cyclopentyl-5-methyl-2,6-bis((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one is an impurity of Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.